EUVIMEDEUVIMED entdecken
Crossref

Are NCCN and EAU Active Surveillance Criteria Reliable in Patients With ISUP Grade‐2 Intermediate‐Risk Prostate Cancer? A Novel Model Integrating MRI to Predict Adverse Pathology

Serdar Madendere iD, Barış Esen, Umut Can Karaarslan, Mustafa Müdüroğlu, Mert Veznikli, Bengi Gürses, Metin Vural, Dilek Ertoy Baydar, Mehmet Onur Demirkol, Yakup Kordan, Tarık Esen

The Prostate · 2026

DOI: 10.1002/pros.70073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, 2026. Verfasst von Serdar Madendere und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, VKV American Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Magnetic Resonance Imaging, Watchful Waiting, Prostate. Die Arbeit nennt 28 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To assess adverse pathology (AP) rates in patients with grade group (GG) 2 prostate cancer (PCa) based on biopsy characteristics and treated with radical prostatectomy (RP). Performance of active surveillance (AS) guidelines in distinguishing patients with AP has also been investigated.

Methods

Records of 345 patients who underwent RP for GG 2 disease detected in prostate biopsy were retrospectively reviewed. Patients with suspicion of extracapsular disease on imaging, PSA ≥ 20 ng/dL, unavailable biopsy data, and in‐bore biopsy were excluded from the study. AP was defined as the presence of ISUP GG ≥ 3 or extracapsular disease. AP rates in patients meeting the AS criteria of NCCN and EAU guidelines were recorded. A novel model was developed to determine AP predictors by using a multivariable logistic regression analysis and a backward stepwise method.

Results

Among 231 patients, median age was 64 (45–79), median PSA was 6.1 (1.2–19) ng/dL. According to biopsy and clinical characteristics, 124 patients (53.7%) met the NCCN, 31 patients (13.4%) met the EAU AS criteria. Pathological examination after RP revealed AP in 105 patients (45.5%); GG ≥ 3 disease in 31 (13.4%), pT3a disease in 78 (33.7%), pT3b disease in 18 (7.8%), and pN1 disease in four patients (1.7%). AP rates in patients meeting NCCN and EAU criteria were 37.9% and 22.6%, respectively. Age ( > 63.5), PSA level ( > 5.04 ng/dL), GG2 PCa‐bearing index lesion size on mpMRI ( > 11.5 mm), maximum tumor length/core length ( > 51.5%) and Gleason Pattern 4 percentage (>%17.5) were independent predictors of AP in our new model.

Conclusions

NCCN AS criteria were associated with nearly a twofold higher rate of AP compared with patients meeting EAU criteria. Our new model, including parameters derived from age, PSA, mpMRI and biopsy characteristics, demonstrated superior performance relative to both NCCN and EAU criteria regarding AP prediction among patients with GG 2 PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMagnetic Resonance ImagingWatchful WaitingProstateHumansMaleAgedMiddle AgedRetrospective StudiesNeoplasm GradingProstatectomyProstate-Specific AntigenBiopsy

Stichwörter der Autor:innen

active surveillancemultiparametric magnetic resonance imagingprostate cancertargeted biopsy

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, VKV American Hospital, Istanbul, Turkey.
  • Department of Urology, Koç University School of Medicine, Istanbul, Turkey.
  • Department of Biostatistics, Koç University School of Medicine, Istanbul, Turkey.
  • Department of Radiology, Koç University School of Medicine, Istanbul, Turkey.
  • Department of Radiology, VKV American Hospital, Istanbul, Turkey.
  • Department of Pathology, Koç University School of Medicine, Istanbul, Turkey.

ORCID-Profile: Serdar Madendere

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Madendere, S., Esen, B., Karaarslan, U. C., Müdüroğlu, M., Veznikli, M., Gürses, B., Vural, M., Baydar, D. E., Demirkol, M. O., Kordan, Y., & Esen, T. (2026). Are NCCN and EAU Active Surveillance Criteria Reliable in Patients With ISUP Grade‐2 Intermediate‐Risk Prostate Cancer? A Novel Model Integrating MRI to Predict Adverse Pathology. The Prostate. https://doi.org/10.1002/pros.70073

Vancouver

Madendere S, Esen B, Karaarslan UC, Müdüroğlu M, Veznikli M, Gürses B, et al. Are NCCN and EAU Active Surveillance Criteria Reliable in Patients With ISUP Grade‐2 Intermediate‐Risk Prostate Cancer? A Novel Model Integrating MRI to Predict Adverse Pathology. The Prostate. 2026. doi:10.1002/pros.70073

BibTeX
@article{Madendere2026,
  author = {Madendere, Serdar and Esen, Barış and Karaarslan, Umut Can and Müdüroğlu, Mustafa and Veznikli, Mert and Gürses, Bengi and Vural, Metin and Baydar, Dilek Ertoy and Demirkol, Mehmet Onur and Kordan, Yakup and Esen, Tarık},
  title = {Are NCCN and EAU Active Surveillance Criteria Reliable in Patients With ISUP Grade‐2 Intermediate‐Risk Prostate Cancer? A Novel Model Integrating MRI to Predict Adverse Pathology},
  journal = {The Prostate},
  year = {2026},
  doi = {10.1002/pros.70073}
}
Kostenlos starten →